Incannex Healthcare Archives | Page 3 of 5 | Cannabiz

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

by Martin Lane July 22, 2022April 29, 2024

Incannex Healthcare has received ethics approval for a phase one clinical trial of its cannabinoid-based anti-inflammatory […]

Dr Sud Argawal steps down from Incannex board

by Martin Lane June 28, 2022April 29, 2024

Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira

by Martin Lane June 8, 2022April 29, 2024

Company news: Helius; Cannvalate; Incannex; Medleaf

by Martin Lane May 19, 2022April 29, 2024

Incannex progresses APIRx acquisition

by Martin Lane May 13, 2022April 29, 2024

Company news: Incannex; Emyria; Creso Pharma; Zelira; MGC Pharma

by Martin Lane May 11, 2022April 29, 2024

Company news: Releaf Group; Cann Group; Foliumed; MGC Pharma; Incannex

by Martin Lane April 28, 2022April 29, 2024

Company news: Medigrowth; Greenfern Industries; Incannex; Cannatrek; MediPharm Labs; Cresco Labs

by Martin Lane March 24, 2022April 29, 2024

Incannex reports positive results from obstructive sleep apnoea trial

by Martin Lane March 11, 2022April 29, 2024

Company news: Emyria; Incannex; Epsilon; AusCann

by Martin Lane March 8, 2022April 29, 2024